Skip to main content
Cancer Science logoLink to Cancer Science
. 2005 Aug 19;94(5):421–424. doi: 10.1111/j.1349-7006.2003.tb01458.x

Fatty acid‐CoA ligase 4 is overexpressed in human hepatocellular carcinoma

Young Kwan Sung 1, Sun Young Hwang 1, Mi Kyung Park 1, Han Ik Bae 2, Woo Ho Kim 3, Jung‐Chul Kim 1, Moonkyu Kim 1,
PMCID: PMC11160225  PMID: 12824887

Abstract

Fatty acid‐CoA ligase 4 (FACL4) is a central enzyme controlling the unesterified arachidonic acid (AA) level in cells. It has been shown that FACL4 blocks apoptosis and promotes colon carcinogenesis by lowering the cellular level of unesterified AA. Consistent with this, FACL4 is upregulated in colon adenocarcinoma. The status of FACL4 in other tumors including hepatocellular carcinoma (HCC) is not known. Here, we report that FACL4 is overexpressed in human HCC compared with adjacent normal liver tissues. FACL4 mRNA and protein were overexpressed in 5 out of 12 (41.7%) and 3 out of 8 (37.5%) cases of HCC, respectively. Immunohistochemical staining showed strong fine granular intracytoplasmic staining in tumor cells, whereas we observed occasional weak staining in normal liver tissues surrounding the tumors. We found that 14 out of 37 (37.8%) HCC expressed moderate to strong FACL4 immunostaining. Both normal adult and fetal liver tissues showed very weak to no detectable staining, whereas 3 out of 10 (30%) cirrhotic livers expressed weak staining. In addition, we found that 4 out of 8 (50%) human hepatoma cell lines expressed high levels of FACL4 by northern blot analysis. Our results show that FACL4 is a new molecular marker for HCC and suggest that the FACL4 pathway may be involved in liver carcinogenesis. (Cancer Sci 2003; 94: 421–424)

References

  • 1. Wilson DB, Prescott SM, Majerus PW. Discovery of an arachidonoyl coenzyme A synthetase in human platelets. J Biol Chem 1982; 257: 3510–5. [PubMed] [Google Scholar]
  • 2. Cao Y, Traer E, Zimmerman GA, McIntyre TM, Prescott SM. Cloning, expression, and chromosomal localization of human long‐chain fatty acid‐CoA ligase 4 (FACL4). Genomics 1998; 49: 327–30. [DOI] [PubMed] [Google Scholar]
  • 3. Hayakawa M, Ishida N, Takeuchi K, Shibamoto S, Hori T, Oku N, Ito F, Tsujimoto M. Arachidonic acid‐selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol Chem 1993; 268: 11290–5. [PubMed] [Google Scholar]
  • 4. Sapirstein A, Spech RA, Witzgall R, Bonventre JV. Cytosolic phospholipase A2 (PLA2), but not secretory PLA2, potentiates hydrogen peroxide cytotoxicity in kidney epithelial cells. J Biol Chem 1996; 271: 21505–13. [DOI] [PubMed] [Google Scholar]
  • 5. Reid T, Ramesha CS, Ringold GM. Resistance to killing by tumor necrosis factor in an adipocyte cell line caused by a defect in arachidonic acid biosynthesis. J Biol Chem 1991; 266: 16580–6. [PubMed] [Google Scholar]
  • 6. Tang DG, Chen YQ, Honn KV. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc Natl Acad Sci USA 1996; 93: 5241–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Chan TA, Morin PJ, Vogelstein B, Kinzler KW. Mechanisms underlying nonsteroidal antiinflammatory drug‐mediated apoptosis. Proc Natl Acad Sci USA 1998; 95: 681–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM. Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci USA 2000; 97: 11280–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Cao Y, Dave KB, Doan TP, Prescott SM. Fatty acid CoA ligase 4 is up‐regulated in colon adenocarcinoma. Cancer Res 2001; 61: 8429–34. [PubMed] [Google Scholar]
  • 10. Kutchera W, Jones DA, Matsunami N, Groden J, Mclntyre TM, Zimmerman GA, White RL, Prescott SM. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci USA 1996; 93: 4816–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183–8. [DOI] [PubMed] [Google Scholar]
  • 12. Koga H, Sakisaka S, Ohishi M, Kawaguchi T, Taniguchi E, Sasatomi K, Harada M, Kusaba T, Tanaka M, Kimura R, Nakashima Y, Nakashima O, Kojiro M, Kurohiji T, Sata M. Expression of cyclooxygenase‐2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology 1999; 29: 688–96. [DOI] [PubMed] [Google Scholar]
  • 13. Shiota G, Okubo M, Noumi T, Noguchi N, Oyama K, Takano Y, Yashima K, Kishimoto Y, Kawasaki H. Cyclooxygenase‐2 expression in hepatocellular carcinoma. Hepatogastroenterology 1999; 46: 407–12. [PubMed] [Google Scholar]
  • 14. Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG, Ryu WS. Expression of cyclooxygenase‐2 (COX‐2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX‐2 inhibitor, NS‐398. Clin Cancer Res 2001; 7: 1410–8. [PubMed] [Google Scholar]
  • 15. Sung YK, Hwang SY, Park MK, Farooq M, Han IS, Bae HI, Kim JC, Kim M. Glypican‐3 is overexpressed in human hepatocellular carcinoma. Cancer Sci 2003; 94: 259–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Park JG, Lee JH, Kang MS, Park KJ, Jeon YM, Lee HJ, Kwon HS, Park HS, Yeo KS, Lee KU, Kim ST, Chung JK, Hwang YJ, Lee HS, Kim CY, Lee YI, Chen TR, Hay RJ, Song SY, Kim WH, Kim CW, Kim YI. Characterization of cell lines established from human hepatocellular carcinoma. Int J Cancer 1995; 62: 276–82. [DOI] [PubMed] [Google Scholar]
  • 17. Cao Y, Murphy KJ, Mclntyre TM, Zimmerman GA, Prescott SM. Expression of fatty acid‐CoA ligase 4 during development and in brain. FEBS Lett 2000; 467: 263–7. [DOI] [PubMed] [Google Scholar]
  • 18. Sung YK, Moon C, Yoo JY, Moon C, Pearse D, Pevsner J, Ronnett GV. Plunc, a member of the secretory gland protein family, is up‐regulated in nasal respiratory epithelium after olfactory bulbectomy. J Biol Chem 2002; 277: 12762–9. [DOI] [PubMed] [Google Scholar]
  • 19. Faergeman NJ, Knudsen J. Role of long‐chain fatty acyl‐CoA esters in the regulation of metabolism and in cell signalling. Biochem J 1997; 323: 1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Hertz R, Magenheim J, Berman I, Bar‐Tana J. Fatty acyl‐CoA thioesters are ligands of hepatic nuclear factor‐4alpha. Nature 1998; 392: 512–6. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Science are provided here courtesy of Wiley

RESOURCES